1 completed. 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
| Phase 3 | 1 | Completed 1 |
Follow this drug Literature Review of fruquintinib+sintilimab trials Research Report on fruquintinib+sintilimab
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of Fruquintinib in Combination With Sintilimab in Advanced Renal Cell Carcinoma (FRUSICA-2) fruquintinib+sintilimab, axitinib / everolimus, fruquintinib - Advanced Renal Cell Carcinoma | Phase 2 / Phase 3 | Completed | Hutchmed | 265 | 2022-10-27 | 2026-10-20 |
Hutchmed (1)
China (1)
Dingwei Ye (1) · Zhi Song He (1)